Form 4: Amphastar Pharmaceuticals Director Receives Stock Grant
Insider Transaction (Form 4)
Anthony T Pierce, a Director of Amphastar Pharmaceuticals, Inc., reported multiple transactions in common stock on July 9, 2026.
Summary
- Grant/award: acquired 7,886 Common Stock on July 9, 2026; holds 7,886 after (Direct).
- Grant/award: acquired 16,646 Stock Option (right to buy) on July 9, 2026; holds 16,646 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Anthony T Pierce — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-09 | Grant/award | Common Stock | 7,886 | — | — | 7,886 |
| 2026-07-09 | Grant/award | Stock Option (right to buy) | 16,646 | — | — | 16,646 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-09 | Grant/award (7,886 shares) |
| 2026-07-09 | Grant/award (16,646 shares) |
Keywords
insider transaction, Form 4, AMPH, Amphastar Pharmaceuticals, Inc., neutral, Anthony T Pierce
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.